Generic KRKA to receive damages in Nexium case

28-01-2014

Generic KRKA to receive damages in Nexium case

Photo: jcjgphotography / Shutterstock.com

The UK High Court has decided to award Slovenian generic pharmaceutical company KRKA damages after a preliminary injunction enforced against the company by AstraZeneca was discharged.


AstraZeneca, KRKA, Nexium, Emozul, generic pharmaceuticals, UK High Court

LSIPR